series-a
Stage
1
Investors
About
NTx Bio develops automated, continuous-flow biomanufacturing platforms for scalable, high-quality RNA and protein production, enabling on-demand RNA synthesis with applications in research, therapeutics, and personalized medicine.
Explore NTx Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.